Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 2 (2005), Issue 10 (October)

1. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
   Curr Med Res Opin, 21(9): 1453-60. [Abstract] [Full-text]
2. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
   Curr Med Res Opin, 21(9): 1363-8. [Abstract] [Full-text]
3. Complement activation and protein adsorption by carbon nanotubes.
   Mol Immunol, 43(3): 193-201. [Abstract] [Full-text]
4. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
   Cancer Chemother Pharmacol, 56(6): 603-9. [Abstract] [Full-text]
5. Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis.
   Cancer Chemother Pharmacol, 56(6): 594-602. [Abstract] [Full-text]
6. Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.
   Cancer Chemother Pharmacol, 56(6): 563-8. [Abstract] [Full-text]
7. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
   Cancer Chemother Pharmacol, 56(6): 569-77. [Abstract] [Full-text]
8. A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer.
   Cancer Chemother Pharmacol, 56(6): 623-8. [Abstract] [Full-text]
9. Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients.
   J Clin Endocrinol Metab, 90(10): 5765-8. [Abstract] [Full-text]
10. Menopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells?
    J Clin Endocrinol Metab, 90(10): 5528-35. [Abstract] [Full-text]
11. Chemopreventive effects of aloe against genotoxicity induced by benzo[a]pyrene.
    J Toxicol Environ Health A, 68(21): 1841-60. [Abstract] [Full-text]
12. Photodynamic damages induced by a monocationic porphyrin derivative in a human carcinoma cell line.
    Int J Biochem Cell Biol, 37(12): 2504-12. [Abstract] [Full-text]
13. Local inner-ear drug delivery and pharmacokinetics.
    Drug Discov Today, 10(19): 1299-306. [Abstract] [Full-text]
14. Pharmaceutical prescribing for children. Part 1. Introduction and general principles of prescribing for children.
    Prim Dent Care, 12(4): 123-6. [Abstract] [Full-text]
15. Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer.
    Cancer Immunol Immunother, 54(12): 1180-90. [Abstract] [Full-text]
16. A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation.
    Cancer Immunol Immunother, 54(12): 1172-9. [Abstract] [Full-text]
17. Complications after photodynamic therapy.
    Arch Ophthalmol, 123(10): 1347-50. [Abstract] [Full-text]
18. Transient serous retinal detachment in classic and occult choroidal neovascularization after photodynamic therapy.
    Am J Ophthalmol, 140(4): 758-60. [Abstract] [Full-text]
19. The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration--a value-based reappraisal with 5-year data.
    Am J Ophthalmol, 140(4): 679-87. [Abstract] [Full-text]
20. Persistence and adherence with topical glaucoma therapy.
    Am J Ophthalmol, 140(4): 598-606. [Abstract] [Full-text]
21. The basics and underlying mechanisms of mucoadhesion.
    Adv Drug Deliv Rev, 57(11): 1556-68. [Abstract] [Full-text]
22. The use of mucoadhesive polymers in ocular drug delivery.
    Adv Drug Deliv Rev, 57(11): 1595-639. [Abstract] [Full-text]
23. The use of mucoadhesive polymers in buccal drug delivery.
    Adv Drug Deliv Rev, 57(11): 1666-91. [Abstract] [Full-text]
24. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.
    Adv Drug Deliv Rev, 57(11): 1640-65. [Abstract] [Full-text]
25. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems.
    Adv Drug Deliv Rev, 57(11): 1583-94. [Abstract] [Full-text]
26. Implementation of a tight glycaemic control protocol using a web-based insulin dose calculator.
    Anaesthesia, 60(11): 1093-100. [Abstract] [Full-text]
27. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.
    J Natl Cancer Inst, 97(20): 1532-8. [Abstract] [Full-text]
28. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
    N Engl J Med, 353(16): 1673-84. [Abstract] [Full-text]
29. Oestrogen and stroke in women: assessment of risk.
    Lancet Neurol, 4(11): 743-51. [Abstract] [Full-text]
30. Appropriateness of use of medicines in elderly inpatients: qualitative study.
    BMJ, 331(7522): 935. [Abstract] [Full-text]
31. Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy.
    Biochem Biophys Res Commun, 337(3): 928-35. [Abstract] [Full-text]
32. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload.
    Biomaterials, 27(4): 660-9. [Abstract] [Full-text]
33. Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A.
    Biochem Pharmacol, 70(10): 1518-26. [Abstract] [Full-text]
34. Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.
    Leukemia, 19(11): 1880-6. [Abstract] [Full-text]
35. Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.
    Leukemia, 19(11): 1929-33. [Abstract] [Full-text]
36. The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio.
    Leukemia, 19(11): 1969-76. [Abstract] [Full-text]
37. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 63(4): 1037-44. [Abstract] [Full-text]
38. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention.
    Cytokine Growth Factor Rev, 16(6): 625-36. [Abstract] [Full-text]
39. Induction of cell death by photodynamic therapy with a new synthetic photosensitizer DH-I-180-3 in undifferentiated and differentiated 3T3-L1 cells.
    Biochem Biophys Res Commun, 337(4): 1059-64. [Abstract] [Full-text]

© 2004-2012 Chemotherapy Research Today. All Rights Reserved.